To estimate the duration of efficacy with continued treatment of double-blind flibanserin or placebo over twenty-four weeks of treatment.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
749
flibanserin flexible dosing
Duration of efficacy of flibanserin in Sexually Satisfying Events
Time frame: 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
511.74.01051 Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
511.74.01027 Boehringer Ingelheim Investigational Site
Mobile, Alabama, United States
511.74.01029 Boehringer Ingelheim Investigational Site
Scottsdale, Arizona, United States
511.74.01031 Boehringer Ingelheim Investigational Site
Tucson, Arizona, United States
511.74.01004 Boehringer Ingelheim Investigational Site
Jonesboro, Arkansas, United States
511.74.01053 Boehringer Ingelheim Investigational Site
Little Rock, Arkansas, United States
511.74.01033 Boehringer Ingelheim Investigational Site
Palm Springs, California, United States
511.74.01003 Boehringer Ingelheim Investigational Site
Palo Alto, California, United States
511.74.01015 Boehringer Ingelheim Investigational Site
Sacramento, California, United States
511.74.01013 Boehringer Ingelheim Investigational Site
San Diego, California, United States
...and 55 more locations